We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

8 hedge funds and large institutions have $208K invested in TriSalus Life Sciences Warrant in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

7.37% less ownership

Funds ownership: 8.07% → 0.71% (-7.4%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

58% less funds holding

Funds holding: 19 → 8 (-11)

85% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 13

94% less capital invested

Capital invested by funds: $3.71M → $208K (-$3.5M)

Holders
8
Holders Change
-11
Holders Change %
-57.89%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WAM
Wolverine Asset Management
Illinois
+$19.8K
2
GS
GTS Securities
New York
+$17.7K
3
FVWA
Foster Victor Wealth Advisors
South Carolina
+$1.34K

Top Sellers

1
MF
Magnetar Financial
Illinois
-$1.17M
2
DM
Deerfield Management
New York
-$543K
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$430K
4
MP
MSD Partners
New York
-$217K
5
BCM
Bluefin Capital Management
New York
-$211K
Name Holding Trade Value Shares
Change 		Change in
Stake
VI
1
Vestcor Inc
New Brunswick, Canada
$74K -$105K -77,923 -52%
FVWA
2
Foster Victor Wealth Advisors
South Carolina
$33.2K +$1.34K +1,000 +5%
HF
3
HRT Financial
New York
$29K -$2.26K -1,681 -6%
ACM
4
Alpha Capital Management
Texas
$22.4K – – –
CAC
5
Cowen and Company
New York
$20.6K – – –
WAM
6
Wolverine Asset Management
Illinois
$14.9K +$19.8K +14,751 New
GS
7
GTS Securities
New York
$13.8K +$17.7K +13,132 New
TRCT
8
Tower Research Capital (TRC)
New York
$42 – – –
MF
9
Magnetar Financial
Illinois
– -$1.17M -642,163 Closed
DM
10
Deerfield Management
New York
– -$543K -333,333 Closed
PAMP
11
Polar Asset Management Partners
Ontario, Canada
– -$430K -259,262 Closed
MP
12
MSD Partners
New York
– -$217K -133,333 Closed
BCM
13
Bluefin Capital Management
New York
– -$211K -115,989 Closed
BCL
14
Bracebridge Capital LLC
Massachusetts
– -$151K -92,880 Closed
Walleye Capital
15
Walleye Capital
New York
– -$147K -80,883 Closed
CCC
16
Cable Car Capital
California
– -$124K -76,287 Closed
SFA
17
Sequoia Financial Advisors
Ohio
– -$103K -62,187 Closed
CM
18
CastleKnight Management
New York
– -$84.4K -46,371 Closed
Walleye Trading
19
Walleye Trading
New York
– -$82.8K -45,496 Closed
KL
20
KIM LLC
Kansas
– -$34.6K -19,007 Closed
Nomura Holdings
21
Nomura Holdings
Japan
– -$19.7K -10,800 Closed

TLSIW Hedge Fund Activity: Q3 2024 in Review

8 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2024, worth a combined $208K — down 94% from $3.71M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of TLSIW and 2 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $19.8K. The largest seller was Magnetar Financial, exiting entirely with an estimated $1.17M sold.

  • 8 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2024, down from 19 in Q2 2024.
  • Funds reported $208K of TriSalus Life Sciences Warrant stock for Q3 2024, down 94% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q3 2024 and 13 closed out, a net change of -11 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q3 2024 was Wolverine Asset Management, an estimated $19.8K added.
  • The largest TriSalus Life Sciences Warrant seller in Q3 2024 was Magnetar Financial, an estimated $1.17M sold.

Based on aggregated 13F filings for Q3 2024.